Therillia Overview

Founded 2013
Status Private
Latest Deal Type Early Stage VC
Investors 1

Therillia General Information


Developer of novel drug candidates designed to provide proof of concept strategies from pre-clinical to clinical stage. The company's drug therapies develop and deploy scientific platforms to support the proof-of-concept strategies by identifying potential responder patient populations, rational drug combinations and the utility of clinical biomarkers, thus enabling sustainable biopharmaceutical companies to reduce the time and cost of achieving proof of concept data for important new therapeutics.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 1010 Sherbrooke Street West
  • Suite 408
  • Montreal, Quebec H3A 2R7
  • Canada
+1 (514) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Therillia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC Completed Startup

Therillia Executive Team (6)

Name Title Board Seat Contact Info
Michael Dixon Chief Executive Officer, President & Board Member
Ramy Hobeika Controller
Rosa Pierro Executive
Gordon Shore Ph.D Chief Scientific Officer
Pierre Beauparlant Ph.D Chief Business Officer

1 Former Executive

Therillia Board Members (4)

Name Representing Role Since
Jean Lamarre Therillia Board Member 000 0000
Michael Dixon Therillia Chief Executive Officer, President & Board Member 000 0000
Pierre Johnson MD Self Chairman 000 0000
Robert Mcneil Ph.D Sanderling Ventures Board Member 000 0000

Therillia Investors (1)

To view Therillia‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Sanderling Ventures Venture Capital Majority 000 0000 000000 0

Therillia Acquisitions (1)

To view Therillia‘s complete investment and acquisition history, request access »
Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 000000000000 18-Apr-2019 000000000000000000 Biotechnology

Ready to get started?

Request a free trial

Therillia Subsidiaries (1)

Company Name Industry Location Founded
00000 000000000000 Biotechnology Montreal, Canada 0000